J E Lovie-Kitchin1, B Brown. 1. Centre for Eye Research, School of Optometry, Queensland University of Technology, Brisbane, Australia. j.lovie-kitchin@qut.edu.au
Abstract
PURPOSE: We assessed repeatability and intercorrelations of five standard vision tests in subjects with normal vision. METHODS: Seventy-eight subjects (aged 21 to 68 years) completed five measurements each of high- and low-contrast visual acuity, near visual acuity and contrast sensitivity (Pelli-Robson chart). RESULTS: Except for correlations between high- and low-contrast visual acuity (r = 0.78), intercorrelations between tests were low to moderate (r < 0.5). For each measure, variability for the group was about one line on the chart (one triplet for the Pelli-Robson chart) and the minimum variability for an individual subject was about one third of this. On average, 1 to 2 lines can be expected to be lost over the normal lifespan on each test. Variability in responses did not increase significantly with age for any test. CONCLUSIONS: The criterion for judging change on commonly used clinical vision tests is about one line for subjects over a wide age range.
PURPOSE: We assessed repeatability and intercorrelations of five standard vision tests in subjects with normal vision. METHODS: Seventy-eight subjects (aged 21 to 68 years) completed five measurements each of high- and low-contrast visual acuity, near visual acuity and contrast sensitivity (Pelli-Robson chart). RESULTS: Except for correlations between high- and low-contrast visual acuity (r = 0.78), intercorrelations between tests were low to moderate (r < 0.5). For each measure, variability for the group was about one line on the chart (one triplet for the Pelli-Robson chart) and the minimum variability for an individual subject was about one third of this. On average, 1 to 2 lines can be expected to be lost over the normal lifespan on each test. Variability in responses did not increase significantly with age for any test. CONCLUSIONS: The criterion for judging change on commonly used clinical vision tests is about one line for subjects over a wide age range.
Authors: Partho S Kalyani; Amani A Fawzi; Sapna Gangaputra; Mark L van Natta; Larry D Hubbard; Ronald P Danis; Jennifer E Thorne; Gary N Holland Journal: Am J Ophthalmol Date: 2011-10-22 Impact factor: 5.258
Authors: Gary N Holland; Peter J Kappel; Mark L Van Natta; Frank J Palella; Alice T Lyon; Kayur H Shah; Peter R Pavan; Douglas A Jabs Journal: Am J Ophthalmol Date: 2010-05 Impact factor: 5.258
Authors: Ayeswarya Ravikumar; Julia S Benoit; Kelsie B Morrison; Jason D Marsack; Heather A Anderson Journal: Optom Vis Sci Date: 2018-03 Impact factor: 1.973
Authors: William R Freeman; Mark L Van Natta; Douglas Jabs; Pamela A Sample; Alfredo A Sadun; Jennifer Thorne; Kayur H Shah; Gary N Holland Journal: Am J Ophthalmol Date: 2008-01-11 Impact factor: 5.258